Frazier Financial Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-515
Closed -$861 952
2024
Q2
$861 Buy
515
+140
+37% +$250 ﹤0.01% 866
2024
Q1
$698 Buy
375
+75
+25% +$138 ﹤0.01% 823
2023
Q4
$570 Buy
+300
New +$448 ﹤0.01% 798

Other funds holding NBP

Frazier Financial Advisors's NBP Position: Q3 2024 in Review

Frazier Financial Advisors sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2024, closing a stake of 515 shares — an estimated $861 sold.

Frazier Financial Advisors first reported a position in NBP in Q4 2023 and held it in 3 quarters. The position peaked at $861 in Q2 2024. 28 funds tracked by Wall St. Rank hold NBP as of Q3 2024.

  • Frazier Financial Advisors reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Frazier Financial Advisors sold 515 NovaBridge Biosciences American Depositary Shares shares in Q3 2024, an estimated $861.
  • Frazier Financial Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2023 and held it in 3 quarters.
  • Frazier Financial Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $861 in Q2 2024.
  • 28 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2024.

Based on Frazier Financial Advisors's 13F filing for Q3 2024, filed 6 Nov 2024.